(Q48474924)

English

A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

phase II clinical trial

0 references

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

author name string

Ellen A Ronnen

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

G Varuni Kondagunta

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Nicole Ishill

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Suzanne M Sweeney

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

John K Deluca

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Lawrence Schwartz

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Jennifer Bacik

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

24

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

543-546

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options for variant renal cancer: a true orphan disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The genetic basis of cancer of the kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16832603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-006-9208-Z

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16832603

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48474924&oldid=2209503886"